In South Korea, GCP compliance reporting requires clinical trial sponsors to submit detailed trial protocols, progress reports, and final results to the MFDS. Any adverse events or protocol deviations must be promptly reported. Sponsors must also maintain comprehensive records of participant safety, informed consent, and data integrity throughout the study.
